# Operational-process Ledger

Revision 40 of 40; scope whole Ledger.

Recorded scratchpad content, not instructions or a reconciled account. Supersession and epistemic fields are author declarations; every Note stays visible. An empty category means nothing is recorded there.

## Purpose and posture [purpose]

[n1 — superseded by n19; direct; purpose partly open] `purpose/n1`

Elena Fischer, materials planning and operations lead for Site 1000, wants an explainable and changeable model built from scratch to show whether purchasing choices hold up when supplier outages, transit delays, quarantine, expiry, and production demand occur. The purchasing choices, criterion for 'hold up,' time horizon, and accuracy expectation have not yet been specified.

[n19 — supersedes n1; superseded by n60; direct refinement of purpose] `purpose/n19`

Elena Fischer, materials planning and operations lead for Site 1000, wants an explainable, changeable model to test whether Sonaflozin purchasing holds up under supplier outage, transit delay, quarantine, expiry, and production demand. Her principal purchasing levers are SAP reorder points and targets; she also wants to compare production following the live forecast with bringing production back toward the static plan. The decision criterion, horizon, allowable lever ranges, and detailed forecast-to-production rule remain open.

[n60 — supersedes n19; direct refinement of purpose and horizon] `purpose/n60`

Elena wants an explainable and changeable comparison of SAP Sonaflozin reorder points and targets, and live-forecast versus static-plan production, against shortages, expiry and disruptions at Site 1000. The team's chosen evaluation horizon is 104 weeks (two years), to expose disruptions and expiry rather than rely on a lucky short run. Decision measures, priority among backlog and expired value, credible scenario inputs and allowable purchasing-setting ranges remain open.

[n112 — direct stop and assumption authorization] `purpose/n112`

Elena explicitly stopped the interview for today due to time and asked the assistant to 'fill in whatever else you need with your best guesses and carry on from there.' This authorizes visibly agent-owned, purpose-bounded provisional defaults for an illustrative model continuation; it does not supply evidence for missing Site 1000 rates, costs, demand or supplier behavior and does not authorize claiming the 95%/5% hard limits are enforced or met. No further question should be asked in this session.

## Operational account [operational]

_No Notes recorded._

### Goals, measures and constraints [operational/goals]

[n17 — direct objective; agent reporting measure labelled] `operational/goals/n17`

Elena wants to know whether purchasing choices hold up; an observed harm in the delayed-shipment case was two delayed production orders and growing backlog (n4, n9). A saved count of waiting production orders can report backlog, but no agreed definition of an acceptable result, on-time rate, decision horizon, or candidate purchasing alternatives yet exists.

[n21 — direct comparison, mechanisms open] `operational/goals/n21`

Elena wants to test whether production should follow the live forecast or be brought back toward the static plan. How each would change order timing or production demand, and how to judge the trade-off against backlog, inventory and expiry, remain unestablished.

[n25 — direct preference and agent measurement implication] `operational/goals/n25`

In the last-autumn forecast-spike case, Elena disliked the resulting excess finished stock, despite there being no backlog problem; she explicitly does not know whether the static plan would have been better. Testing the policy requires tracking finished stock after demand is served, not simply counting produced batches or treating all production as sales.

[n29 — direct with open threshold] `operational/goals/n29`

For the forecast-versus-static-plan comparison, Elena's excess-stock concern is expiry: after overproduction and a quiet period finished stock may not have enough remaining life to be useful. Customer orders are the stated drawdown mechanism in that case (n27). The acceptable expiry loss and how to value it relative to backlog remain open.

[n63 — superseded by n66; direct hard constraints and objective; denominator open] `operational/goals/n63`

For comparisons over 104 weeks, Elena requires customer fill rate at least 95% and expiry below 5% of material over the period. Among policies meeting BOTH limits, choose the one with lower overall cost; if a more costly qualifying option is considered, she wants an explanation of why. Whether fill rate measures units or orders, immediate versus eventual fulfillment, and what counts in the expiry denominator ('material' by units, value, received or purchased) remain open. These are hard decision limits, not optional weights to fold into cost.

[n66 — supersedes n63; superseded by n84; direct tentative definition; hard limit retained] `operational/goals/n66`

Elena is not certain of a precise formal fill-rate definition for this model. She proposes that a customer order is a MISS if it does not ship on time, whether eventually delivered late or cancelled. In practice, a late delivery to a contract customer causes a lateness payment; a spot customer who cancels while waiting is a lost sale. The 95% minimum is retained as her intended limit, but whether the rate counts orders or units, what sets each due time, and how cancellations/partial shipments count remain unresolved. This is Elena's provisional proposed operational definition, not a measured reporting specification.

[n72 — direct cost classes; scope and values open] `operational/goals/n72`

Elena says 'overall cost' for comparing qualifying policies includes purchase cost, storage, disposal when material is rejected or expires, production shortage cost when a batch cannot run, and switching cost for an emergency move to German Supplier. She previously named contract lateness payments and spot-customer lost sales (n67); whether these are included in the overall cost total rather than tracked beside it needs confirmation. No amounts, currencies, per-unit/event/time bases, or aggregation rule have been supplied.

[n84 — supersedes n66; superseded by n87; direct tentative normalization; limits remain hard] `operational/goals/n84`

Elena retains two hard limits over 104 weeks: at least 95% customer fill and STRICTLY BELOW 5% expired material. She tentatively proposes an order as a miss if it fails to ship on time, including later shipment or cancellation; exact fill-rate denominator remains undefined (n67–n68). For material expiry she assumes a unit-based fraction, expired units divided by total units 'handled in the period,' calculated SEPARATELY for Sonaflozin and Flowbind. 'Handled' needs definition (starting stock, purchases, receipts, consumption) before calculating a fraction; a value-based expiry measure has not been defined. Among policies meeting all limits, lower overall cost wins, but total-cost inputs remain incomplete.

[n87 — supersedes n84; superseded by n93; direct clarification; denominator now specified] `operational/goals/n87`

Elena defines each material's 104-week expiry fraction tentatively but now with an explicit denominator: expired units divided by OPENING STOCK UNITS PLUS NEW RECEIPTS for that material over the period, counting each unit once as it enters the period, not once per handling movement or production use. Compute Sonaflozin and Flowbind separately and require each strictly below 5%. She calls this 'the sensible way'; it is her accepted operational definition for this model, not independent historical-report evidence. Treatment of material that expires before receipt and opening stock's observation instant still needs care. The 95% customer fill and overall-cost conditions remain as in n84.

[n93 — supersedes n87; direct refined measure] `operational/goals/n93`

For each of Sonaflozin and Flowbind separately over 104 weeks, Elena's proposed expiry fraction counts expired units only after Site 1000 receipt/entry into stock, divided by opening stock units plus new receipt units, each unit counted once. Pre-receipt ageing loss is outside this SITE expiry percentage and may be treated as quality rejection, per n92. Each fraction must be strictly below 5%; on-time customer fill at least 95% and lower overall cost among qualifying policies remain the other decision conditions. Exact treatment of a lot rejected at receipt and who bears its cost is unsettled.

### Boundary and initial conditions [operational/boundary]

[n3 — direct; mechanisms open] `operational/boundary/n3`

Elena names supplier outages, transit delays, quarantine, expiry, and production demand as conditions purchasing must allow for; their causal paths, timing, and consequences are not yet established.

[n9 — direct incident] `operational/boundary/n9`

In an earlier Sonaflozin incident customs held the shipment, two production orders were delayed before it arrived, backlog built, and no material was scrapped. Quality chased paperwork while purchasing considered whether the shipment should be regarded as lost; no loss-declaration rule or recovery path has yet been established.

### Participants, things and resources [operational/resources]

[n2 — direct] `operational/resources/n2`

Site 1000 makes Sonic Flow from Sonaflozin and Flowbind Material. Their quantities, units, sourcing, handling, and production consumption are not yet specified.

[n38 — superseded by n42; direct; referent ambiguous] `operational/resources/n38`

Elena identifies Indian supplier as supplying Flowbind Material in 2,500-unit increments and German Supplier as handling 250-unit top-ups. Her wording does not unambiguously say which material the German Supplier tops up or when a top-up is chosen; do not assign it to a specific material yet.

[n42 — supersedes n38; direct correction and operational rule] `operational/resources/n42`

Correction from Elena: German Supplier supplies emergency Flowbind Material top-ups only; it does not supply Sonaflozin. Indian supplier is the regular Flowbind source in 2,500-unit increments. German Supplier handles 250-unit top-ups when Flowbind stock is below 500 units or Indian supplier is out. This is not a routine order. The precise meaning of 'stock' (released versus all on hand), outage recognition and release, ordering/arrival time and quarantine for top-ups remain open.

### Activities and resource use [operational/activities]

[n6 — direct case; unconfirmed generalization] `operational/activities/n6`

For the described Sonaflozin purchase, a shipment arrived and entered quarantine; after a few days it was released and could be used for the waiting production run. Whether quarantine can fail, who has release authority, and whether any stock can be used before release are not yet established.

[n7 — direct with modelling gaps] `operational/activities/n7`

In the described case, a production run waited for released Sonaflozin and then produced a successful Sonic Flow batch. Elena has identified Flowbind Material as another ingredient, but its availability, quantity used, batch size, and whether both ingredients must be jointly present at start are not yet established.

[n27 — direct with gaps] `operational/activities/n27`

Elena says customer orders drew down finished Sonic Flow stock after production; in the case she described, nothing else drew it down. The timing and sizes of customer orders, allocation across batches and any shipments rejected for insufficient remaining shelf life have not yet been specified.

[n50 — direct; valuation open] `operational/activities/n50`

When either material expires it is removed from usable stock and its value written down, according to Elena. Unit cost or write-down value by material, handling of partly consumed lots, and timing of record updates remain unspecified.

[n68 — direct alternative outcomes with gaps] `operational/activities/n68`

A customer order can be shipped on time, delivered late to a contract customer with a lateness payment, or cancelled by a waiting spot customer as a lost sale in Elena's examples. Due date, order quantity, timing and decision process for cancellation, and any partial fulfillment are not specified; these routes cannot yet be assigned probabilities.

[n106 — direct quality gate and outcomes] `operational/activities/n106`

Quality holds ALL incoming raw-material lots in quarantine and checks delivery against order: identity, quantity, packaging, damage and supplier certificate of analysis. Passing lot is quality-released to usable stock; failing lot is rejected, removed from Site 1000 inventory and disposed of at a cost. Before checking, Elena says the team cannot tell which lots will fail. The charged disposal amount and fate of supplier credit/replacement are unknown.

### Cases and process spine [operational/process-spine]

[n4 — direct remembered cases] `operational/process-spine/n4`

Elena's last-spring Sonaflozin case: inventory position fell below the reorder point; SAP triggered an order to Chinese Supplier; the shipment arrived and went into quarantine; quality released it after a few days; a production run had already been waiting; the batch ran and was fine. Contrasting earlier case: a shipment was delayed at customs for 'something like six weeks'; two production orders were delayed and backlog built before arrival; nothing was scrapped; quality chased paperwork while purchasing considered whether to treat the shipment as lost. Neither case establishes a general loss or scrap rule.

[n23 — direct remembered case] `operational/process-spine/n23`

Elena recalls last autumn: over a few weeks larger spot orders caused the live forecast to jump; production chased it with bigger batches; demand later dropped and Site 1000 had more finished Sonic Flow stock than needed. There was no backlog problem in that case. This is a contrasting production/demand case, not evidence that the static plan would have performed better.

### Time, quantities and variation [operational/quantities]

[n8 — direct approximate] `operational/quantities/n8`

For Sonaflozin from Chinese Supplier, Elena described around four weeks to expected receipt as normal, and release from quarantine after 'a few days' in the last-spring case. An earlier customs delay lasted 'something like six weeks'; whether that was total transit time or additional delay is unknown. These are recollections, not measured distributions.

[n13 — direct] `operational/quantities/n13`

Elena says each unit of Sonic Flow in a production order uses one unit of Sonaflozin and one unit of Flowbind Material. A typical batch is around 700 Sonic Flow units and thus needs roughly 700 units of each input. This is a per-unit recipe; 'around' and 'roughly' describe batch size, not uncertainty about the one-to-one recipe.

[n14 — direct] `operational/quantities/n14`

Elena says a 2,500-unit Sonaflozin shipment can cover several production orders; it must not be treated as one batch's worth or as one unit of stock. In the delayed-shipment case, released Sonaflozin on hand was insufficient for the two delayed production orders and the delayed shipment was relied on; Flowbind was sufficient in that case. No general starting stock, demand arrival rate, or order-size policy has yet been established.

[n28 — person report of records; approximate] `operational/quantities/n28`

Elena says Sonic Flow has a 'relatively short shelf life, something like 28 weeks from what I can see in the records.' This is an approximate account of records she has seen, not a record independently consulted here. The start of shelf-life counting, whether there is a customer minimum remaining-life requirement, and the disposition of expired stock are not yet established.

[n33 — direct current settings] `operational/quantities/n33`

For Sonaflozin at Site 1000, Elena reports SAP reorder point 2,500 units and target 7,500 units. The minimum order quantity needed for the stated rounding rule has not been supplied. These are current settings to test, not proven sufficient levels.

[n39 — person report; context preserved] `operational/quantities/n39`

Elena says Sonaflozin purchase orders in SAP come in 2,500-unit increments and 'would round up to the nearest 2,500'; Flowbind orders from Indian supplier are similarly 2,500-unit increments, and German Supplier top-ups are 250 units. Whether 2,500 is an exact contractual MOQ or an observed SAP increment, and the material and trigger for German top-ups, remain open.

[n44 — direct] `operational/quantities/n44`

Elena reports Flowbind emergency threshold strictly below 500 units and German Supplier top-up quantity 250 units. The Indian regular Flowbind supply increment is 2,500 units (n39). These should not be conflated into one order-size distribution or treated as equivalent suppliers.

[n48 — superseded by n56; person report of records; approximate contextual range] `operational/quantities/n48`

Elena reports that, according to records she has seen, current Sonaflozin lots have somewhere between 88 and 156 weeks of remaining life. This is a range across current lots, not an asserted probability distribution, and does not establish the total supplier shelf life or the remaining life on future receipts.

[n49 — superseded by n55; person-reported assumption; basis missing] `operational/quantities/n49`

Elena says no batch expiry records are available for Flowbind, so 'we've assumed 156 weeks.' This is an operating assumption, not observed lot-specific expiry; whether 156 weeks denotes total life from supplier or estimated remaining life on hand is not yet clear.

[n55 — supersedes n49; direct clarification of team assumption] `operational/quantities/n55`

Elena clarifies that the team's 156-week Flowbind figure is an assumption of REMAINING life on CURRENT STOCK at the time they look at records, not total life from manufacture or a life assigned to new supplier orders. The team made this assumption because it had no better batch expiry records. Any transit and quarantine after that observation reduce what remains; do not present the assumption as measured or as a starting life for future German/Indian lots.

[n56 — supersedes n48; direct contextual clarification] `operational/quantities/n56`

For CURRENT Sonaflozin lots, Elena says the 88–156-week figures are remaining life as of the time records are viewed; subsequent transit and quarantine consume some of that remaining life. This is a range of current lot readings, not supplier-start life for future orders or a sampling distribution. Record observation date and which lot/location each value refers to remain unknown.

[n61 — direct team decision] `operational/quantities/n61`

The team chose a 104-week evaluation horizon for purchasing and production comparisons. Elena's reason: two years gives supplier disruptions and expiry enough time to show up, rather than a short run looking lucky. This is a chosen test horizon, not evidence for any disruption frequency or expiry rate.

[n75 — person report of SAP data; approximate] `operational/quantities/n75`

Elena reports approximate purchase prices from SAP: Chinese Supplier (Sonaflozin) EUR 89 per unit; Indian supplier (Flowbind) EUR 110 per unit; German Supplier (Flowbind emergency source) EUR 82 per unit. These are approximate reported SAP figures, not independently consulted here; purchase conditions and effective dates have not been provided.

[n76 — person report of data; semantics open] `operational/quantities/n76`

Elena reports a Sonic Flow profit figure of roughly EUR 55 per unit 'from the data.' The exact source, whether this is gross contribution or net after any of the enumerated costs, and which sold units earn it are unclear; do not silently treat this as price or double count it in an objective.

[n77 — direct team estimate and evidence limit] `operational/quantities/n77`

Elena identifies EUR 5,000 as a team estimate of the supplier-switching cost when using German Supplier in an emergency. Storage, production shortage, disposal, and lateness cost figures are likewise team estimates based on 'reasonable industry figures,' not measured at Site 1000, but their numeric values and units have not been supplied.

[n82 — direct uncertainty and confirmation requirement] `operational/quantities/n82`

Elena does not have the team-estimated production-shortage cost figure at hand. She believes its charging basis is per unit short, NOT per batch, but explicitly warns this is imprecise and must be confirmed before a specific number is put in the model. The exact figure and what counts as a 'unit short' (unproduced versus delayed versus lost) remain unknown.

[n98 — direct settings] `operational/quantities/n98`

For regular Flowbind purchasing from Indian supplier, Elena reports reorder point 1,500 units, target 5,000 units, order increments 2,500 units. These are current settings, not proven optimal; EUR 110/unit is the separately reported approximate SAP purchase price (n75).

[n107 — direct approximate mean; team assumption] `operational/quantities/n107`

Elena says raw-material quarantine hold is around FOUR DAYS ON AVERAGE. She says the team assumes ABOUT 5% of lots are rejected, drawn from general industry figures rather than Site 1000 quality records. No actual duration distribution, rejection independence by supplier/material, period, denominator or observed local rate has been supplied; 5% is not the separate <5% site-expiry limit.

### Policies and exceptions [operational/policies]

[n5 — superseded by n32; direct with local gaps] `operational/policies/n5`

For the described Sonaflozin case, SAP triggered an order to Chinese Supplier when the inventory position dropped below the reorder point. The meaning of inventory position, reorder point value, order size, whether this is automatic or requires purchasing approval, and applicability to other materials are unknown.

[n20 — direct uncertainty and source distinction] `operational/policies/n20`

Site 1000 has reorder-point and target values in SAP. Elena is not confident these account for expiry and supplier disruption; she suspects they 'were probably set to cover a comfortable lead time and that's it.' This is her uncertainty about how they were set, not an established historical SAP-setting rule. The actual numbers and operational meaning of 'target' have not been supplied.

[n24 — direct contextual contrast] `operational/policies/n24`

In the last-autumn case, production responding to the live forecast made batches bigger as forecast demand jumped. Elena says the static plan would have kept batches around 700 units regardless. Exact live-forecast batch sizes, release frequency and any cap or smoothing rule are unknown. This statement is a case-specific contrast, not a universal batch-size policy for all conditions.

[n32 — supersedes n5; superseded by n37; direct; inventory formula hedged and rounding ambiguous] `operational/policies/n32`

Elena says Sonaflozin inventory position includes on-hand stock plus stock already on order, 'I believe.' When position drops below the reorder point, an order is placed to bring it toward the target: the described quantity is target minus current position, 'rounded up to the minimum order quantity.' For Sonaflozin she gives reorder point 2,500 and target 7,500 units. The meaning of rounding (minimum floor versus multiples), minimum-order-quantity value, whether quarantined or in-transit material is included, and whether SAP triggers automatically or a person places the order remain unsettled.

[n37 — supersedes n32; direct clarification; still hedged] `operational/policies/n37`

Elena clarifies that Sonaflozin purchase orders in SAP come in 2,500-unit increments, and says MOQ rounding is to whole multiples, 'I think.' Under her reported current rule, an order below the 2,500-unit reorder point brings SAP position toward the 7,500-unit target, rounded up to the nearest 2,500 units. Her inventory-position definition (on hand plus on order) also remains hedged 'I believe'; this is a plausible rule to check against SAP examples, not independently verified configuration.

[n43 — direct; repetition and authority unknown] `operational/policies/n43`

For emergency Flowbind supply, Elena states an either/or trigger: Flowbind stock drops below 500 units, OR Indian supplier is out. The German Supplier supplies a 250-unit top-up, and never Sonaflozin. Whether several top-ups can be outstanding or are repeated during a prolonged outage, and who authorizes the order, is unknown.

[n47 — direct operational rule] `operational/policies/n47`

Elena says both Sonaflozin and Flowbind Material can expire. Material shelf-life clock starts at the supplier and runs through preparation, transit and quarantine before stock is available. At expiry the material is removed and its value written down; it cannot be used in production. This rules out treating quarantine release as the beginning of shelf life.

[n67 — direct contextual paths, no universalization] `operational/policies/n67`

For customer-order outcomes, Elena distinguishes a contract customer delivered late (incurs a lateness payment) from a spot customer who cancels while waiting (lost sale). Her proposed miss condition is any customer order not shipped on time. She has not said all late spot orders cancel, that contract orders cannot cancel, or how long the lateness/cancellation decision takes.

[n92 — direct boundary clarification with 'likely' preserved] `operational/policies/n92`

For the proposed Site 1000 expiry measure, Elena says to count material in the site's expiry figure only ONCE IT HAS BEEN RECEIVED AND ENTERED SITE STOCK. A Sonaflozin shipment expiring before arrival would 'likely be flagged as a quality rejection rather than expiry from our perspective'; this is tentative classification, not a universal disposition or cost-liability rule. Material that expires after receipt while quarantined is inside the site measure under the stated boundary.

[n97 — direct rule and scope] `operational/policies/n97`

Elena says routine Flowbind purchasing from Indian supplier follows the same reorder-to-target logic as Sonaflozin: when Flowbind inventory position falls below its reorder point, order toward target, rounded UP in 2,500-unit increments. Flowbind's current reorder point is 1,500 units and target 5,000 units. This describes order sizing, not yet Indian supplier timing, outage handling or quarantine behavior.

[n102 — direct universal gate as stated] `operational/policies/n102`

Elena states that ALL incoming raw materials at Site 1000 must enter quarantine and pass quality release before production can use them. This includes Sonaflozin and Flowbind regardless of supplier: Chinese, Indian or German emergency top-ups. Physical receipt alone never makes stock production-usable. Release timing, rejection rates and paperwork differences by supplier remain unknown.

### Validation evidence and sources [operational/validation]

[n73 — superseded by n78; direct provenance distinction, mapping open] `operational/validation/n73`

Elena says some cost inputs came from SAP while others were estimated by the team because the data did not contain them, and she knows which is which. The mapping of each cost component to SAP or estimate, extraction dates, and estimate rationale have not yet been given. Neither SAP nor underlying records were consulted here.

[n78 — supersedes n73; direct provenance mapping] `operational/validation/n78`

Elena maps approximate supplier purchase prices (Chinese EUR 89/unit, Indian EUR 110/unit, German EUR 82/unit) to SAP; Sonic Flow profit roughly EUR 55/unit is described as 'from the data,' without a precise source here. EUR 5,000 German supplier-switching, plus storage, production shortage, disposal and lateness figures, are team estimates called 'reasonable industry figures,' not measured at Site 1000. These are Elena's reports of data and estimates, not independently verified source extracts; SAP effective dates and estimate rationales remain open.

[n108 — direct provenance with agent candidate validation] `operational/validation/n108`

The assumed approximately 5% quarantine rejection rate is based on general industry figures, not Site 1000 measured rejection records, per Elena. A local sequence of receipt/quality-decision timestamps and rejection reasons by material and supplier could test both the assumed rate and roughly four-day average, but no such source was consulted here.

## Construction notes [construction]

[n10 — agent representation and stand-ins] `construction/n10`

Using n4–n9, constructed a partial order-to-release fragment: an externally supplied SAP reorder signal leads to a Sonaflozin purchase order, a provisional supplier-dispatch step, transit, an externally supplied arrival/clearance notice, quarantine, and an externally supplied quality-release notice before available Sonaflozin. Shipment timing, customs holds, quarantine release criteria, reorder threshold and supplier outage have not been encoded as causal or timed rules; external notices stand in until these are established. Count represents orders/shipments rather than material quantity. Supplier dispatch as a separate step is agent modelling inference, not a described event.

[n11 — superseded by n15; agent provisional structure; partial] `construction/n11`

Using n2, n4, n7, added unconnected production-order waiting, Flowbind-availability, and finished-batch states to sketch the other end of the operation. Did not wire a production conversion: one shipment yielding one batch or unlimited use would be unsupported. Need quantities and how released stock is allocated before making production consume inputs. Expiry, supplier outage, backlog measures, demand generation and purchasing alternatives also remain outside connected behavior.

[n15 — supersedes n11; agent construction revision] `construction/n15`

Revision after Elena supplied the per-unit recipe and 2,500-unit shipment in n13–n14: represent separate numeric material stocks and order demand quantities, so one shipment can serve several orders and producing a batch reduces both available ingredients by the ordered units. The earlier unconnected states were provisional; quantity conservation now requires typed stock rather than order-count stock. No duration or fractional-batch rule inferred.

[n16 — agent representation and explicit simplifications] `construction/n16`

Following n13–n14, revised the draft to carry integer units on Sonaflozin orders, shipments, quarantine, aggregate released Sonaflozin, aggregate Flowbind, production orders and completed batches. A release adds shipment units to the aggregate stock. A production-order completion is guarded by both available balances covering the order, subtracts its units from both and records equal Sonic Flow units. Stock balances require one initialized token each even when zero. Atomic completion without duration, exact 700-unit order sizes, single aggregate stock with no lot identity, and absence of partial allocation are modelling simplifications or as-yet-unelicited details, not established operating policy. The 2,500-unit order parameter is only an adjustable example from n14, not a general order size.

[n22 — agent decision to defer ineffective knobs] `construction/n22`

The existing external SAP reorder signal and externally supplied production orders still do not respond to reorder-point/target settings or forecast-vs-static production policy. Introducing standalone parameters without a sourced decision rule would make the apparent levers ineffective, so no net mutation was made on this answer. Need the stock-position and forecast-to-order behavior before wiring these choices.

[n26 — agent structural review and gap] `construction/n26`

The current coloured production-order demand already allows different requested batch units, including approximately 700 and larger values, so this answer does not require a net mutation to represent batch quantity. It does not yet implement live-forecast or static-plan order generation, spot-order arrival, demand falling back, sales/finished-stock depletion, or expiry. The currently saved output is cumulative produced units, not remaining finished stock; do not use it as an excess-stock measure.

[n30 — agent transformation and visible assumptions] `construction/n30`

Using n27–n29, revised produced batches into unshipped finished lots carrying unit quantity and age; time in this fragment is interpreted as weeks. Age advances one week per simulation week from the modelled instant of production completion. A customer order can consume units from one lot while preserving the lot's age; an approximate 28-week cutoff moves remaining units to an 'expired' tally. Saved metrics report current unshipped units and cumulative units passing the cutoff. Age starts at completion, the 28-week point is a hard provisional boundary despite Elena's approximate record-based wording, and customer orders requiring several lots are not currently fulfillable. These are agent modelling choices requiring correction; no assertion of actual scrapping or customer remaining-life requirement is made. Material expiry remains unmodelled.

[n34 — agent revision requirement] `construction/n34`

The old adjustable 2,500-unit example order size (n16) must be replaced: current Sonaflozin order quantities follow the position-to-target rule in n32, not a fixed shipment size. Position still needs an SAP-supplied reading until the hedged on-hand plus on-order interpretation, coverage of quarantined stock, and inventory updates are settled. MOQ rounding is ambiguous; a provisional multiples interpretation would require an explicit stand-in and later correction.

[n35 — superseded by n40; agent stand-in and structural limitation] `construction/n35`

Using n32–n33, replaced the fixed 2,500-unit example-order knob with net parameters for the reported 2,500-unit Sonaflozin reorder point and 7,500-unit target. A coloured, externally supplied SAP position snapshot now enables ordering below the point and sizes an order toward the target. Since the MOQ amount and rounding meaning are unknown, agent provisional rule rounds to the next whole multiple of a named MOQ parameter initialized to 1 unit only as a placeholder; this is not Elena's MOQ. Removed the old fixed-size parameter. The SAP snapshot is external: the net does not recompute it from on-hand plus on-order, so repeated/stale snapshots could cause spurious orders and a threshold change is not a trustworthy stress test yet.

[n40 — supersedes n35; agent construction refinement] `construction/n40`

Following n37–n39, replaced the Sonaflozin MOQ=1 placeholder with Elena's reported 2,500-unit SAP order increment. The position-to-target calculation rounds upward in 2,500-unit multiples; the Sonaflozin reorder point and target remain 2,500 and 7,500 units. 'I think' still qualifies the reported multiples rule, and SAP position remains externally supplied rather than recalculated. No Flowbind or German Supplier path was added yet because the material for the 250-unit top-ups and switching trigger are unresolved.

[n45 — agent structure and explicit stand-ins] `construction/n45`

Using n42–n44, added a Flowbind-only German Supplier emergency branch: reported usable Flowbind balance below 500 units or an externally supplied Indian Supplier outage can produce a 250-unit pending top-up; a separately supplied receipt notice adds it to Flowbind balance. The Indian regular 2,500-unit path is not yet constructed. One outstanding top-up at a time is an agent anti-duplicate stand-in, not an elicited policy. A persistent outage indicator can retrigger orders after each receipt; receipt-to-usable-stock bypasses any quarantine whose applicability is unknown, and German lead time is external. Without initial Flowbind balance and event schedules this is structural only.

[n51 — superseded by n52; agent required structural revision] `construction/n51`

n47–n50 invalidate the earlier aggregate released-material balances as an expiry-faithful representation: aggregating lots loses each lot's remaining life, and starting a timer only at quality release would contradict the supplier-start rule. Revise to age-bearing material lots across purchase, transit, quarantine and usable stock before using this draft to test reorder targets against expiry; supplier life for future lots and handling of multi-lot production remain open.

[n52 — supersedes n51; agent representation with explicit placeholder] `construction/n52`

Revised the draft to represent Sonaflozin separately by lots across order, transit, quarantine and usable stock, with remaining life falling one week per simulation week from a provisionally modelled supplier-order start; expired lots are removed to a Sonaflozin unit tally. Flowbind usable and German emergency pending quantities are also individual life-bearing lots with removal to a separate expired-unit tally. Production requires one unexpired lot of each ingredient big enough for the entire order and returns any leftover units with the same remaining life. This supersedes aggregate stock balances; no automatic total-stock summation, multi-lot allocation or financial write-down exists. For future Sonaflozin purchases, 156 weeks at the modelled supplier order is an AGENT PLACEHOLDER drawn from the upper end of the observed current-lot range, not a measured supplier life. For German Flowbind orders 156 weeks uses Elena's assumption but its interpretation remains open. Existing current Sonaflozin lots should instead be initialized with their recorded remaining weeks, not all set to 156.

[n53 — agent structural correction and loss] `construction/n53`

Revised low-Flowbind emergency detection from inspecting one lot (which would falsely treat a small lot as total stock) to reading an externally supplied total Flowbind stock snapshot. The <500 gate is therefore structurally represented but not computed from the lot balances; a stale snapshot can still trigger a false top-up. Likewise Sonaflozin SAP position is still external. Monetary write-down remains unrepresented until unit values are supplied, despite unit-expiry tallies.

[n57 — superseded by n58; agent correction requirement] `construction/n57`

The modelled 156-week age assigned to a newly ordered German Flowbind lot was incorrectly tied to the team's current-stock assumption (n55); replace that parameter's interpretation with an expressly agent-owned future-lot placeholder until supplier expiry/receipt life is known. Current Flowbind lots, if initialized later, may use 156 weeks remaining as the team's provisional current-stock assumption, with observation time explicit. The new Sonaflozin supplier-lot 156-week placeholder is likewise not current-lot evidence.

[n58 — supersedes n57; agent correction applied] `construction/n58`

Corrected the new German Flowbind order parameter: it is now expressly 'unknown new German Flowbind lot life,' with 156 weeks merely an AGENT placeholder, not the team's 156-week remaining-life assumption for current stock (n55). Both emergency-order paths refer to the renamed placeholder. Existing usable Flowbind lots will need separate current-stock initialization with the team's assumed 156 weeks remaining at observation; current Sonaflozin lots likewise require their observed lot-specific remaining life (n56). This correction changed the provenance label and code reference, not demonstrated behavior.

[n62 — agent readiness assessment] `construction/n62`

The draft's material and finished-stock age rates are expressed per simulation week, consistent with the newly stated 104-week comparison horizon; no experiment was drafted because allowable setting ranges, an agreed comparison measure and executable scenario with demand/supplier event timing are not yet available. The horizon does not by itself justify a specific time step, Monte Carlo count or disruption model.

[n64 — agent fidelity and request limitation] `construction/n64`

The current net's waiting-order count and expired-material unit tallies are not a customer fill rate or material-expiry percentage, and it has no cost accounting. Do not advertise them as tests of n63. Petrinaut's AI experiment request cannot enforce the stated 95% fill and <5% expiry limits; any later draft must list both as unsupported hard restrictions with Run blocked unless Elena explicitly accepts reporting-only exploration. No experiment readiness yet: agreed metric definitions, costs, tunable setting ranges and saved executable scenario are absent.

[n69 — superseded by n70; agent revision requirement] `construction/n69`

The existing CustomerOrdersWaiting quantity-only state and shipment step cannot distinguish on-time from late, contract from spot, or cancellation, and therefore cannot report Elena's provisional customer misses. Revise customer order representation to carry due timing and customer kind and preserve outcome categories; any due-time generation or cancellation trigger is external until Elena supplies it. No numeric lateness-payment or lost-sale cost should be invented.

[n70 — supersedes n69; agent partial implementation and explicit losses] `construction/n70`

Revised the draft customer-order state to carry requested units, weeks to due date and contract-versus-spot kind. Waiting due time counts down per simulation week. Separate pathways represent one-lot on-time shipment, one-lot late contract shipment, and externally signalled spot cancellation; saved metrics count on-time shipments and candidate misses (late contract shipments, cancelled spot orders, still-waiting past-due orders). This is a candidate ORDER-count interpretation of n66, NOT an agreed fill-rate formula or verified 95% test. Due dates, customer demand generation and cancellation events remain external; late spot orders not cancelled have no shipment path, cross-lot fulfillment is missing, and lateness payments/lost-sale values are not costed. A cancelled order is counted even if cancellation preceded due time; this reflects no shipment but still needs Elena's definition check.

[n74 — agent deferral of unsupported amounts] `construction/n74`

No cost coefficients or total-cost metric were added from n72: the categories are established but their numerical rates, units, provenance and whether customer penalties/lost sales join the total are not. Existing counters for expiration and customer outcomes cannot be interpreted as monetary cost; 'production shortage' also cannot be equated to every waiting order without a due/running schedule. Ask for sourced versus estimated coefficients before building cost accounting.

[n79 — agent cost-accounting boundary] `construction/n79`

Cost inputs n75–n77 support separately labelled purchase-spend and German-switching event counters where their purchase paths are modelled. They do not yet support a total-cost objective: Indian regular purchase path is absent; storage/shortage/disposal/lateness values are missing, and the EUR 55 profit figure is not semantically clear enough to net against spend. A German unit price below Indian price must be preserved as reported, not silently 'corrected' to a conventional emergency premium.

[n80 — agent partial cost construction] `construction/n80`

Using n75, n77–n79, added named approximate SAP price parameters EUR 89/unit for Chinese Sonaflozin and EUR 82/unit for German Flowbind, and team-estimated EUR 5,000 per German emergency order. At modelled placement of a Chinese order or German emergency top-up, separate cumulative EUR event states now record purchase commitment and, for German orders, switching expense; saved metrics sum them separately. Charging when an order is placed is an agent accounting convention, not observed SAP cash timing. Indian EUR 110/unit, unpriced storage, shortage, disposal, lateness and the ambiguous EUR 55/unit profit are NOT included; these metrics are partial components and must not be treated as overall cost. No values were invented for absent costs.

[n83 — agent decision to preserve unknown] `construction/n83`

No production-shortage cost parameter or monetary charge was created: n82 establishes only a tentative per-unit basis and forbids a guessed figure. The draft's waiting-order count is not equivalent to units short and cannot be priced until the shortage event/unit and team estimate are confirmed. Re-enter from Elena's team costing record or estimate.

[n85 — superseded by n88; agent fidelity choice] `construction/n85`

The two existing expired-ingredient unit tallies are candidate numerators for Elena's separate Sonaflozin and Flowbind <5% limits. No denominator or percentage metric was added because 'total units handled in the period' has not been operationally defined, Indian regular receipts and initial stock are not represented, and a zero denominator would need a rule. Do not pool the two materials or treat the partial unit tallies as evidence that either limit is met.

[n88 — supersedes n85; superseded by n90; agent revision requirement] `construction/n88`

With n87, the expiry denominator is opening stock plus new receipts per material, each unit counted once. The draft currently lacks opening-stock and incoming-receipt cumulative tallies and pools pre-receipt Sonaflozin expiry with site-held expiry, so its current expired-unit metrics are not the specified percentages. Revise numerator/denominator representation before testing <5%, with explicit treatment for in-transit expiry and the absent Indian Flowbind path.

[n90 — supersedes n88; agent partial measure construction] `construction/n90`

Using n87, added cumulative receipt-unit counters: a Sonaflozin arrival into quarantine counts once as a Site 1000 receipt, and a German Flowbind receipt counts once at its receipt event. These are candidate new-receipt portions of each material's 104-week 'opening stock + new receipts' denominator. No opening-stock record is initialized, Indian regular Flowbind receipts are absent, and current expired-unit tallies still include lots expiring before receipt; therefore no expiry fraction or 5% compliance test was added. Ask whether pre-receipt expiry is included in Site 1000's numerator before splitting those tallies. Counter values and timing have not been behaviorally tested.

[n94 — superseded by n95; agent revision requirement] `construction/n94`

The current expiry-event sinks violate n93 because Sonaflozin ordered/in-transit and German Flowbind pending lots feed the same expired-unit counters as received/site-held lots. Redirect pre-receipt expiry to separate counters and reserve the existing ingredient expired-unit metrics for quarantined or available stock after receipt; do not yet price pre-receipt rejection without liability evidence.

[n95 — supersedes n94; agent structural correction applied] `construction/n95`

Revised expiry sinks to match n92–n93: Sonaflozin lots passing their life boundary before dispatch or during transit now accumulate in a separate pre-receipt loss tally; German Flowbind top-ups passing it before receipt likewise accumulate separately. Existing Sonaflozin and Flowbind expired-unit metrics now count only received lots, including Sonaflozin in quarantine. Receipt-unit counters were retained as denominator fragments. This is structural separation, not an adjudication of whether supplier quality rejection or Site 1000 pays the pre-receipt loss. Opening-stock counters, Indian regular Flowbind arrivals and final denominator/percentage metrics remain absent; zero-denominator policy also unspecified.

[n99 — superseded by n100; agent proposed projection] `construction/n99`

The routine Indian Flowbind path, absent until n97, can now use an externally supplied Flowbind inventory-position snapshot, 1,500/5,000/2,500 sizing and reported EUR 110/unit commitment. A receipt event, future supplier-lot remaining life and any quarantine are still missing; represent those as external/agent stand-ins and do not infer that Indian outage blocks order placement versus dispatch without Elena's account.

[n100 — supersedes n99; superseded by n103; agent applied structural projection with losses] `construction/n100`

Built a regular Indian Flowbind path from an EXTERNALLY supplied inventory-position reading: below 1,500 units, order toward target 5,000 rounded upward in 2,500-unit increments; approximate SAP purchase commitment EUR 110/unit is recorded. The resulting ordered lot ages while awaiting an externally supplied receipt notice, then enters usable Flowbind stock and the site receipt-unit tally; if it ages out before receipt, it goes to pre-receipt loss, outside site expiry. Initial remaining life 156 weeks on NEW Indian lots is explicitly an AGENT PLACEHOLDER, not the team's current-stock 156-week assumption. Receipt direct to usable stock (quarantine unresolved), and absence of explicit Indian-outage gating (its effect can only be reflected in externally supplied receipt timing) remain losses. No comparison scenario or 5% denominator is complete.

[n103 — supersedes n100; superseded by n104; agent structural correction requirement] `construction/n103`

Correction required from n102: the provisional Indian and German Flowbind paths that moved directly from site receipt to usable stock are WRONG. Redirect both receipts into quarantined Flowbind lots, with age still decreasing; only a quality-release event moves a nonexpired lot into usable Flowbind, and post-receipt expiry in quarantine counts in the Site 1000 numerator. Preserve receipt counters at physical entry, not at quality release. No supplier-specific quarantine duration inferred.

[n104 — supersedes n103; agent applied correction] `construction/n104`

Corrected both Indian regular and German emergency Flowbind receipt paths: physical receipt now counts units entering Site 1000 and places each ageing lot into Flowbind quarantine, NOT usable stock. A separate externally supplied quality-release event moves only a nonexpired quarantined lot into production-usable Flowbind; quarantine expiry moves its units to the site-received expiry tally. Existing Sonaflozin receipt/quarantine/release path already matched Elena's rule. Neither quality-release delay nor quality-rejection outcome has been inferred.

[n109 — superseded by n110; agent transformation scope] `construction/n109`

The existing quality-release notices can continue to be external triggers; add a distinct externally signalled rejection path from each quarantine state to rejected/disposed-unit tallies, separate from life-expiry tallies. Do not silently turn a four-day average into a deterministic hold or assume an exponential distribution; do not convert the industry 5% into a locally observed rate. Both figures can be saved as labelled parameters when a timing/outcome mechanism is chosen. Disposal cost remains unpriced.

[n110 — supersedes n109; agent applied partial quality branch] `construction/n110`

Added separate externally signalled inspection-failure routes for Sonaflozin and Flowbind quarantined lots. A rejected unexpired lot leaves quarantine, cannot be used in production, and contributes to a separate quality-rejected-unit tally; this is distinct from age expiry and from pre-receipt losses. Quality release and rejection both consume the same lot, so the two routes compete structurally; no source event generator chooses between them yet. Elena's about-5% industry-assumed rejection probability and around-four-day average quarantine hold are NOT encoded as a stochastic distribution, since no distribution/tail or supplier-specific timing has been established. Disposal EUR and replacement/credit remain unknown.

[n113 — superseded by n115; agent bounded continuation plan] `construction/n113`

Following Elena's stop and permission for guesses, a small illustrative initial-state scenario may be built to exercise known recipe and order/customer flow with explicitly agent-chosen opening stock and due dates. It must NOT be described as a 104-week policy test or used to compare purchasing settings: actual lot opening quantities, demand time series, supplier receipt events, inventory-position updates, outage and customs behavior, rejection timing/outcomes, complete cost and hard-limit accounting are still unavailable. Prefer a labelled smoke-test scenario over inventing full-horizon random rates as if grounded.

[n115 — supersedes n113; agent authorized, visibly bounded defaults] `construction/n115`

After Elena authorized agent guesses and stopped, added a SAVED illustrative one-batch scenario for a structural walkthrough, not a 104-week comparison. Agent-selected starting balances: one 2,500-unit released Sonaflozin lot with 100 weeks remaining (within the current-lot 88–156 range but not an observed lot), one 2,500-unit released Flowbind lot with 156 weeks remaining (the team's assumption applied to illustrative current stock), one 700-unit production order and one 700-unit contract customer order due in one week (agent due-date guess). Opening quantities and that single order/customer coincidence are agent inventions for demonstration; 700 reflects an approximate typical batch. Scenario parameters expose these starting values for later edits. No supplier receipts, outage, rejection or continuing demand is scheduled. No simulation or scenario compilation was run; net function-code diagnostic after writing scenario code reported no net errors but explicitly does not check scenario/metric compilation.

## Cross-cutting open matters [open-matters]

[n65 — superseded by n86; consequential unresolved measures] `open-matters/n65`

For n60–n63, customer fill rate, material expiry percentage and overall cost are load-bearing but their numerators/denominators, timing, valuation and trade-off are not yet sufficiently specified. This prevents determining which purchasing or production setting qualifies or wins. Return when Elena can define the measures or identify the Site 1000 reports and costing inputs used to calculate them.

[n86 — supersedes n65; superseded by n89; open measure refinement] `open-matters/n86`

The two expiry limits are now tentatively per-material expired units / 'units handled' over 104 weeks (n84), not a combined value-based rate; what counts as handled still blocks their measurement. Customer fill remains tentatively on-time order count without an agreed denominator; total cost has only two partial event components and a missing shortage estimate. These gaps block qualification and ranking of purchasing/production policies. Return with Site 1000's report definitions for handled units and fill rate, plus the team estimates and SAP-supported cost bindings.

[n89 — supersedes n86; open measure gap narrowed] `open-matters/n89`

The material-expiry denominator has been resolved to opening stock plus new receipts separately for each material (n87), but the draft still needs those event counts and a decision on losses before site receipt. The on-time customer fill denominator, complete cost rates/valuation, initial stocks and supplier/demand time series still block comparing policies over 104 weeks. Return with site reports or sample cases to bind the remaining measures.

[n114 — deferred at stop] `open-matters/n114`

At Elena's explicit stop, load-bearing inputs still missing across n60, n93, n97, n102, n107: timed customer/production demand and due dates; opening per-lot stocks and supplier life for future lots; reliable SAP inventory-position and Flowbind total-stock updates; supplier outage/lead-time and customs-delay regimes; quarantine timing/rejection realization; customer fill denominator; storage/shortage/disposal/lateness EUR rates and profit semantics; multi-lot allocation. These prevent a credible 104-week comparison and qualifying policies under the 95% customer and separate <5% material-expiry limits. Re-enter later with Site 1000 records and Elena's definition of fill rate and candidate setting ranges; do not resolve by unlabelled guesses.

## Delivery status [delivery]

[n12 — superseded by n18; tool evidence scoped] `delivery/n12`

Current construction is partial: accepted mutation results and inspected definition show the Sonaflozin order-to-quality-release path and three currently unconnected production-related states; this is not an end-to-end purchase-to-production model. Agent structural review finds the receipt and release notices to be named external stand-ins and production connection absent. Net code diagnostic reported no errors or warnings, but no scenario/metric compilation, simulation, behavioral validation, or stock accounting check has occurred. A title update reported success but the subsequent canonical read still returned 'New Process', so title persistence is unresolved.

[n18 — supersedes n12; superseded by n31; tool evidence and agent structural review; partial] `delivery/n18`

Current partial draft has an inspected connected order-to-release path and a connected production step using unit balances for Sonaflozin and Flowbind; stock and waiting-order initial populations still require a scenario. A saved time-series metric counts waiting orders. Net function-code diagnostic reported no errors or warnings after code edits; it does not compile scenarios/metrics or demonstrate execution. Agent structural review finds the 1:1 recipe and stock deduction in place, but reorder calculation, stochastic or timed supplier behavior, customs, quarantine delay, expiry, backlog timing and purchasing alternatives remain absent or externally supplied. No simulation or behavioral validation occurred. Net-title mutation reported success but canonical read still says 'New Process'; title persistence remains unresolved.

[n31 — supersedes n18; superseded by n36; partial; tool and agent review scoped] `delivery/n31`

Current inspected draft connects the Sonaflozin order-to-quality-release path, 1:1 ingredient-consumption production, unshipped finished lots, customer order drawdown and a provisional finished-life cutoff. Saved metrics count waiting production orders, unshipped finished units and cumulative units passing the example cutoff. Code diagnostics found no errors or warnings, but saved scenario/metric compilation and execution have not been checked; agent structural review only. No initial-state scenario or behavioral run exists. Reorder-point/target mechanism, live-versus-static generation, supplier outages, realistic delays/quarantine, raw-material expiry and multi-lot fulfillment remain absent or externally supplied. Title-change success report still disagrees with canonical 'New Process' read.

[n36 — supersedes n31; superseded by n41; partial; current tool evidence scoped] `delivery/n36`

Latest inspected partial net includes an externally supplied SAP inventory-position snapshot guarded at reported reorder point 2,500 units, order-to-target calculation at 7,500 units with unknown MOQ placeholder, and the previously reviewed purchase, production, customer-drawdown and finished-life fragments. Code diagnostic reports no net function-code errors or warnings. No scenario, executed run, behavioral validation or trustworthy automatic inventory-position update exists; MOQ interpretation, supplier outages/delays, production scheduling and material expiry remain open. Structural review is limited to correspondences of the visible draft, not decision readiness. Canonical read still reports title 'New Process' despite earlier title-setting acknowledgement.

[n41 — supersedes n36; superseded by n46; tool/schema and review scoped] `delivery/n41`

Inspected structure now calculates Sonaflozin orders from externally supplied SAP position using the reported 2,500-unit increment, not a 1-unit placeholder; net function-code diagnostics showed no errors or warnings after the code update. Existing production, finished-stock age, customer drawdown, and metrics are unchanged. This remains a partial, structurally reviewed draft without a saved scenario, behavioral run or evidence that SAP position and orders update correctly during simulation; Flowbind and German top-ups are not connected. Title persistence still unresolved.

[n46 — supersedes n41; superseded by n54; partial; no behavioral claim] `delivery/n46`

Inspected outline includes a new Flowbind-only emergency branch for <500 usable units or Indian supplier outage, 250-unit German top-up and externally signaled receipt, in addition to earlier Sonaflozin, production and finished-stock fragments. Agent static structural review finds corresponding gates and Flowbind stock addition; direct usability, repeated-outage orders and one-pending-order rule remain agent stand-ins. Latest net code diagnostic reports no errors or warnings. There remains no scenario, executed behavior, reliable automated SAP inventory position, Indian normal replenishment path or integrated forecast plan. Canonical title still reads 'New Process' despite prior acknowledged rename.

[n54 — supersedes n46; superseded by n59; partial; tool and agent review scoped] `delivery/n54`

Latest inspected outline now shows supplier-ageing Sonaflozin lots across purchase/transit/quarantine/released states, ageing Flowbind usable/German pending lots, expiry removal for both, and saved expired-unit counts. Agent-reviewed structural correspondence applies to these named pathways, not their behavior or numeric fidelity. Net TypeScript diagnostic shows no errors/warnings after code edits; scenario and metric compilation are not checked by that diagnostic. No scenario or execution has occurred. Key blockers for the stated purchasing decision remain: future supplier life, Flowbind 156-week interpretation, lot-level initial stock, reliable stock-position updates, lead-time/outage regimes, regular Indian replenishment, multi-lot production, production-plan and customer demand time series, monetary write-down and comparison horizon. Title still canonically reads 'New Process' despite rename success report.

[n59 — supersedes n54; superseded by n71; partial reviewed artifact; behavior untested] `delivery/n59`

Current inspected draft retains supplier-ageing material-lot paths, emergency Flowbind path, ingredient and finished expiry unit tallies, with corrected distinction between current Flowbind stock's team assumption and agent placeholder for new German lots. Net function-code diagnostics showed no errors/warnings after code updates; no initial-state scenario, metric/scenario compilation test, execution, model-to-SAP reconciliation or purchasing comparison has occurred. Structural review remains partial: SAP position/total Flowbind readings external, future lot life provisional, stock lots cannot be combined into one batch, and supplier disruption/forecast dynamics not implemented. Title still returned as 'New Process' at last canonical read despite earlier rename acknowledgment.

[n71 — supersedes n59; superseded by n81; tool-schema and static review only] `delivery/n71`

Latest mutation/layout result and code diagnostics show a partial draft with customer due-time/kind representation, candidate on-time/late-contract/cancelled-spot routes and counts, in addition to earlier supplier, inventory, production and expiry fragments. Static agent review finds candidate paths but incomplete late-spot, partial-fulfillment, cost, forecast policy, outage timing and position update behavior. Net function-code compilation diagnostic reports no errors/warnings; no saved scenario, scenario/metric execution-time compilation, behavioral simulation, check of 95% or <5% limits, or cost optimization has occurred. The AI experiment request cannot enforce those limits. Last canonical title read reported 'New Process' despite acknowledged rename.

[n81 — supersedes n71; superseded by n91; partial; scoped tool evidence] `delivery/n81`

Current tool-mutated and auto-laid-out draft adds event-based Chinese/German purchase commitments and estimated German switch charge with saved component metrics; code diagnostics reported no errors/warnings after each code edit. Static agent review finds the new price-bearing transitions and distinct EUR tallies in the inspected mutation result, but these exclude Indian regular purchasing and most cost classes. The 95% customer fill and <5% material expiry limits still have no agreed executable definitions and cannot be enforced by the AI experiment request. No scenario, experiment proposal, simulation or behavioral/financial validation has occurred. SAP position/demand/outages still external; title was last read as 'New Process' despite successful rename acknowledgement.

[n91 — supersedes n81; superseded by n96; partial; no behavioral evidence] `delivery/n91`

The inspected post-layout draft now has cumulative modeled Sonaflozin and German Flowbind new-receipt unit events as partial denominators in addition to previous stock, customer-outcome, expiry and partial cost fragments. Net code diagnostics following receipt-kernel edits returned no errors or warnings. Agent static review only: expiry numerators include pre-receipt lots, denominator lacks opening stock and Indian regular supply, so neither <5% limit can be tested. No saved initial-state scenario, execution, behavioral validation, cost ranking, or enforceable 95%/5% experiment exists. Prior canonical title read remained 'New Process' despite acknowledged rename.

[n96 — supersedes n91; superseded by n101; partial net; no execution claim] `delivery/n96`

Latest inspected post-mutation definition separates pre-receipt material losses from post-receipt ingredient-expiry counts and retains Sonaflozin and German Flowbind receipt-unit tallies, alongside previous purchase, production, customer and partial cost pathways. Net TypeScript diagnostics after changed kernels reported no errors/warnings; tool-schema accepted and agent structurally reviewed for this distinction only. There is still no saved scenario, behavioral run, computed 95% fill or 5% per-material expiry fractions, complete cost objective, or enforceable constrained experiment. Opening stock, normal Indian receipts and source-driven timelines are missing. Last canonical title read remained 'New Process' despite rename acknowledgement.

[n101 — supersedes n96; superseded by n105; partial structurally reviewed; execution untested] `delivery/n101`

Latest post-layout inspected net has the regular Indian Flowbind reorder-to-target fragment, reported supplier price and receipt counter in addition to Chinese and German paths, ageing lots, expiry boundaries, production, customer outcomes and partial costs. Code diagnostics after Indian transition edits reported no errors or warnings; no behavioral run or saved scenario exists. Agent static review: candidate arcs/code reflect reported thresholds and increments, but SAP position, supplier notice timing, quarantine applicability, initial lots, future shelf life, multi-lot fulfillment, demand and cost totals are unresolved. Both hard limits remain unmeasured and cannot be enforced by the AI experiment request. Canonical title at last read was 'New Process' notwithstanding rename acknowledgement.

[n105 — supersedes n101; superseded by n111; partial checked structure; no behavior] `delivery/n105`

Latest inspected post-layout definition now structurally puts ALL modelled incoming Sonaflozin and Flowbind lots into quarantine before usable stock, with separate quality-release notices; Flowbind received lots can expire in quarantine and count against Site 1000 expiry units. Code diagnostics after the revised receipt and release kernels reported no errors or warnings. This is agent structural correspondence and schema acceptance, not demonstrated execution. No initial scenario, simulation, reliable automatic SAP positions or finished 95%/5% and total-cost measures exists; supplier lead times, rejection and cost outcomes remain open. Canonical title previously still returned 'New Process' despite rename acknowledgement.

[n111 — supersedes n105; superseded by n116; partial; code diagnostic not execution] `delivery/n111`

Latest inspected post-layout draft includes quality rejection as a distinct lot-removal branch for each material and a saved tally of rejected raw-material units, alongside quarantine release and expiry. Net function-code diagnostic returned no errors/warnings after the new transition and metric code. Agent structural review confirms named paths but not that 5% rejection or four-day mean is reproduced; those remain external and untested. No saved executable scenario, simulation, computed fill/expiry percentages, complete cost measure, enforceable constrained experiment or confirmed title persistence. End-to-end comparisons remain premature.

[n116 — supersedes n111; final partial delivery status; checks scoped] `delivery/n116`

At Elena's explicit stop, the deliverable is a partial, tool-schema-accepted, agent-structurally-reviewed Petrinaut draft with a saved illustrative one-batch initial-state scenario, recipe/inventory ageing, three supplier paths, quarantine release/rejection, provisional customer outcomes and partial EUR cost counters. Net code diagnostics report no errors/warnings; saved scenario/metric compilation and actual execution were NOT performed. It cannot answer whether reorder settings or live-versus-static production hold up over 104 weeks, determine overall-cost winner, or establish 95% fill and separate <5% expiry compliance. Critical missing source and construction inputs are in n114, n89 and n110; hard limits cannot be enforced by the AI experiment request, and no experiment was drafted. The example scenario is demonstrative only and uses agent guesses n115, not Site 1000 starting stock. Last canonical title read was still 'New Process' despite acknowledged rename; title persistence unresolved.
